Cardioprotective Effects of Metalloproteinase Inhibitor 1-({4-[(4-Chlorobenzoyl)amino]phenyl}sulfonyl-L-Proline in Modeled Acute Myocardial Infarction.

MLA

Kryzhanovskii, S. A., et al. “Cardioprotective Effects of Metalloproteinase Inhibitor 1-({4-[(4-Chlorobenzoyl)Amino]Phenyl}sulfonyl-L-Proline in Modeled Acute Myocardial Infarction.” Bulletin of Experimental Biology & Medicine, vol. 168, no. 5, Mar. 2020, pp. 641–45. EBSCOhost, https://doi.org/10.1007/s10517-020-04770-4.

APA

Kryzhanovskii, S. A., Ionova, E. O., Stolyaruk, V. N., Tsorin, I. B., Vititnova, M. B., Grigorkevich, O. S., Mokrov, G. V., & Gudasheva, T. A. (2020). Cardioprotective Effects of Metalloproteinase Inhibitor 1-({4-[(4-Chlorobenzoyl)amino]phenyl}sulfonyl-L-Proline in Modeled Acute Myocardial Infarction. Bulletin of Experimental Biology & Medicine, 168(5), 641–645. https://doi.org/10.1007/s10517-020-04770-4

Chicago

Kryzhanovskii, S. A., E. O. Ionova, V. N. Stolyaruk, I. B. Tsorin, M. B. Vititnova, O. S. Grigorkevich, G. V. Mokrov, and T. A. Gudasheva. 2020. “Cardioprotective Effects of Metalloproteinase Inhibitor 1-({4-[(4-Chlorobenzoyl)Amino]Phenyl}sulfonyl-L-Proline in Modeled Acute Myocardial Infarction.” Bulletin of Experimental Biology & Medicine 168 (5): 641–45. doi:10.1007/s10517-020-04770-4.